Edition:
United Kingdom

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

5.01USD
21 Sep 2018
Change (% chg)

$0.14 (+2.87%)
Prev Close
$4.87
Open
$4.91
Day's High
$5.01
Day's Low
$4.74
Volume
51,733
Avg. Vol
24,260
52-wk High
$8.61
52-wk Low
$3.13

Chart for

About

Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a... (more)

Overall

Beta: --
Market Cap(Mil.): $33.47
Shares Outstanding(Mil.): 6.94
Dividend: --
Yield (%): --

Financials

  NVUS.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -7.20 -- --
ROI: -67.10 15.07 14.61
ROE: -67.53 16.59 16.33

BRIEF-Novus Therapeutics Reports Q4 Loss Per Share $0.30

* Q4 LOSS PER SHARE $0.30 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

02 Apr 2018

BRIEF-Novus Therapeutics Qtrly Loss Per Share $0.30

* QTRLY LOSS PER SHARE $0.30 Source text for Eikon: Further company coverage:

02 Apr 2018

Earnings vs. Estimates